Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug
Resume. It is 41 years in 2018 since Braestrup and Squires opened translocator protein 18 kDa TSPO, known until 2006 as the peripheral benzodiazepine receptor (PBR). The functions of this receptor, which is one of the most important component of the outer mitochondrial membrane, have been studied in...
Saved in:
| Main Authors: | G. V. Mokrov, O. A. Deeva, M. A. Yarkova, T. A. Gudasheva, S. B. Seredenin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2018-11-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/72 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Approaches to predict ligands affinity towards translocator protein TSPO 18 kDa in order to create molecules possessing neuropsychotropic activity
by: N. M. Baraboshkin, et al.
Published: (2019-01-01) -
Search of the correlation berween anxiolytic effect of original derivative of pyrrolo [1,2-A] pyrazine TSPO-LIGAND (GML-1) and its concentrations in the rat blood plasma
by: M. A. Yarkova, et al.
Published: (2018-03-01) -
Assessment of basal TSPO expression and [18F]DPA-714 biodistribution in healthy mice and post-ischemic brain using PET imaging
by: Brígida Gomes de Almeida Schirmer, et al.
Published: (2025-04-01) -
Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a potential anxiolytic drug
by: O. A. Deeva
Published: (2024-01-01) -
Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis
by: Nylund Marjo, et al.
Published: (2025-08-01)